Turret Capital, a healthcare-focused venture firm, has announced the launch of Sable, an innovative biotech-driven consumer beauty company. Supported by pre-seed investments from Turret Capital and SOSV, Sable enters the market with a goal to transform the body care and beauty industry through scientifically advanced topical products. The company leverages proprietary biotech technology to address modern aesthetic needs, offering formulations designed to enhance body contours and improve skin vitality.
Health Technology Insights: Abeona Therapeutics Announces Appointment of Mohamad Tabrizi as Chief Business Officer
Sable’s flagship products are built on scientific breakthroughs at Columbia University Medical Center. A team of leading researchers developed a novel ingredient that selectively targets fat cells, demonstrating in preclinical studies a reduction of up to 70 percent in fat cell volume. This research has been exclusively licensed to Sable, which is now transforming it into topical body creams aimed at delivering visible results safely and effectively.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 15 December 2025
The brand is positioned to meet the growing consumer interest in body aesthetics and longevity. Sable provides targeted solutions for aesthetic contouring, maintenance of results during lifestyle or wellness transitions, and post-treatment support to optimize outcomes from professional body-sculpting procedures. Daniel Chai, MD, Founder and CEO of Sable, stated that the company represents a new frontier in science-to-consumer beauty. He explained that Sable translates complex research into practical, high-performance products that help consumers achieve and maintain their desired body appearance while fostering long-term confidence.
By combining rigorous scientific innovation with consumer-focused design, Sable aims to redefine the standards of topical body care. The company’s approach addresses both the desire for visible, immediate results and the growing demand for sustainable, evidence-based solutions that complement modern wellness and aesthetic practices.
Health Technology Insights: Infinitus Launches Next-Generation Clinical AI Agents
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
